NASDAQ:GLMD
Galmed Pharmaceuticals Ltd. Stock News
$0.407
-0.0119 (-2.84%)
At Close: May 07, 2024
Cantor Fitzgerald Assumes Galmed Pharmaceuticals at Overweight, Lowers Price Target To $14
12:00am, Thursday, 30'th Jan 2020The Daily Biotech Pulse: Novartis Earnings, Hepion's NASH Candidate Beats Rival Drugs, Annovis Bio To Debut
01:30pm, Wednesday, 29'th Jan 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 28) 10X Genomics Inc (NASDAQ: TXG ) Acceleron Pharma I
P.a.w. Capital Corp Buys OptimizeRx Corp, Aptose Biosciences Inc, Orchard Therapeutics PLC, ...
12:00am, Tuesday, 28'th Jan 2020Madrigal: Beyond NASH
05:35pm, Tuesday, 14'th Jan 2020
After the robust Phase 2 NASH data for resmetirom, Madrigal commenced its Phase 3 trial earlier this year. There is another upcoming Phase 3 investigation to st
Is Galmed Pharmaceuticals Ltd.'s (NASDAQ:GLMD) CEO Overpaid Relative To Its Peers?
01:25pm, Friday, 03'rd Jan 2020
Allen Baharaff has been the CEO of Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) since 2012. This analysis aims first to...
Do Hedge Funds Love Galmed Pharmaceuticals Ltd (GLMD)?
12:21am, Sunday, 15'th Dec 2019
Based on the fact that hedge funds have collectively under-performed the market for several years, it would be easy to assume that their stock picks simply aren't very good. However, our research show
Top Ranked Momentum Stocks to Buy for December 4th
02:26pm, Wednesday, 04'th Dec 2019
Top Ranked Momentum Stocks to Buy for December 4th
NASH Scorecard Year to Date: The Winners and the Losers
01:41pm, Friday, 29'th Nov 2019
NASH sees a highly rewarding market with candidates of blockbuster potential. Let us take a look at the hits and misses in this space so far this year.
